2021
DOI: 10.1016/j.clgc.2020.12.007
|View full text |Cite
|
Sign up to set email alerts
|

Cutoff Values of Prostate Imaging Reporting and Data System Version 2.1 Score in Men With Prostate-specific Antigen Level 4 to 10 ng/mL: Importance of Lesion Location

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 30 publications
4
13
0
Order By: Relevance
“…Consistent with another model, ADC was useful for distinguishing TZ cancer from BPH 37 . However, ADC was found to affect diagnostic performance more than T2*, contradicting PI‐RADS 27,28,37 . We consider that this may mean that the importance of DWI images to diagnose TZ cancer might be underestimated in the PI‐RADS scoring system 37 .…”
Section: Discussionsupporting
confidence: 54%
See 3 more Smart Citations
“…Consistent with another model, ADC was useful for distinguishing TZ cancer from BPH 37 . However, ADC was found to affect diagnostic performance more than T2*, contradicting PI‐RADS 27,28,37 . We consider that this may mean that the importance of DWI images to diagnose TZ cancer might be underestimated in the PI‐RADS scoring system 37 .…”
Section: Discussionsupporting
confidence: 54%
“…21,23 According to the recommendations of PI-RADS, lesions in TZ are scored by T2WI and adjusted by DWI. 26,27 However, the described imaging findings of TZ cancers on T2W-MRI in PI-RADS v2 are subjective, and the reporting process is affected by almost inevitable variability among the different readers, making complete reproducibility impossible. 7,14 Consistent with a previous study, glandular BPH present as hyperintense nodules on T2-weighted imaging, a result of T2 shine-through effects, enabling it easy to differentiate from PCa and stromal BPH on T2*.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Prostate-speci c antigen (PSA), a glycoprotein almost entirely secreted by the prostate gland, is considered to be one of the most reliable clinical biomarkers for the diagnosis, screening, and risk prediction of prostate cancer, and it was the rst tumor biomarker approved by the Food and Drug Administration (FDA) [3,4]. For healthy individuals, the serum PSA level is extremely low, about 4.0 ng•mL −1 and more than 10 ng•mL −1 , making them prone to developing prostate cancer [5][6][7]. erefore, the sensitive and accurate detection of serum PSA is critical for monitoring early asymptomatic prostate cancer, increasing the chances of cure and reducing its mortality.…”
Section: Introductionmentioning
confidence: 99%